Determination of the Nail Psoriasis Severity Index improvement rate standards for nail psoriasis treatment in a phase IV clinical trial of ustekinumab: the MARCOPOLO study.

Youn, S W; Kim, B R; Cho, S; Seo, S J; Lee, E S; Roh, J Y; Choi, G S; Lee, M G

Youn, S W; Kim, B R; Cho, S; Seo, S J; Lee, E S; Roh, J Y; Choi, G S; Lee, M G.

Affiliation

Youn SW; Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Kim BR; Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Cho S; Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea.
Seo SJ; SMG-SNU Boramae Medical Center, Seoul, Korea.
Lee ES; Department of Dermatology, Chung-Ang University Hospital, Seoul, Korea.
Roh JY; Department of Dermatology, Ajou University Medical Center, Suwon, Korea.
Choi GS; Department of Dermatology, Gachon University Gil Hospital, Incheon, Korea.
Lee MG; Department of Dermatology, Inha University Hospital, Incheon, Korea.

J Eur Acad Dermatol Venereol ; 31(6): e298-e299, 2017 Jun.

Article in En | MEDLINE | ID: mdl-27976465

Subject(s)

Dermatologic Agents/therapeutic use; Nail Diseases/drug therapy; Psoriasis/drug therapy; Ustekinumab/therapeutic use; Humans; Nail Diseases/etiology; Psoriasis/complications; Severity of Illness Index; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Dermatologic Agents / Ustekinumab / Nail Diseases Type of study: Clinical_trials / Etiology_studies / Guideline / Observational_studies Limits: Humans Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2017 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google